Malcolm Skingle
Director, Academic Liaison at the GlaxoSmithKline.
Malcolm Skingle has a BSc in Pharmacology/Biochemistry and a PhD in Neuropharmacology. He has worked in the pharmaceutical industry for more than 40 years and has gained a wide breadth of experience in the management of research activities. Part of his former role as a research leader in a Neuropharmacology department involved co-supervising collaborations with academics in the UK, Europe and USA. He has more than 60 publications including articles on the interface between industry and academia.
Malcolm manages Academic Liaison at GSK with staff in Stevenage and Philadelphia. His role involves close liaison with several groups outside the Company e.g. Government Departments, Research and Funding Councils and other science-driven organisations. He sits on many external bodies including several UK University Department advisory groups. He also chairs a number of groups including the Diamond (Synchotron) Industrial Advisory Board, the Cogent Science Industry Partnership Board driving skills for the life sciences sector and the ABPI group working on academic liaison.
Visit website: https://www.bps.ac.uk/about/who-we-are/honorary-fellows-directory/dr-malcolm-skingle/87fd56b2-d7f6-e311-88a7-001dd8b721a7
See also: GlaxoSmithKline (GSK) - Research and develop pharmaceutical medicines, vaccines and consumer healthcare products
Details last updated 17-Apr-2021
Malcolm Skingle is also referenced in the following:
UK SPINE 2021 Annual conference
21-Apr-2021 to 23-Apr-2021
Series of events focused on research and innovation in geroscience and ageing therapeutics organized by UK SPINE.